课题基金 / 基金详情

项目摘要

项目成果

Dongfeng Wu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary: Motivated by the need of physicians and patients to make informed decision, probability methods are proposed to address the problem of when to schedule the next exam for an asymptomatic individual with a history of negative screenings. The method provides a screening time interval to limit the risk of being a clinical incident case to a small value, such as 5% or 10%. The time interval is a function of the three key parameters (i.e., screening sensitivity, sojourn time in preclinical state and transition time distribution in disease-free state), a person's current age/gender, smoking status, and one's screening history. Distribution of Lead time (ie. diagnosis time advanced by screening) and probability of over-diagnosis are derived, if one would be diagnosed with cancer at the future scheduled time. A new likelihood function to estimate the three key parameters are proposed and will be validated to increase the accuracy of the estimation. The methods will be applied to four cohorts from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial for lung cancer (PLCO-Lung) and four cohorts from the National Lung Screening Trials (NLST). The specific aims are: 1. To estimate the three key parameters using a new likelihood function in the eight cohorts using either chest X-ray or Low Dose Computed Tomography (CT). Eight cohorts (four from PLCO-Lung using X-ray: male/female smokers, male/female never-smokers; four from NLST: male/female smokers via X-ray, male/female smokers via CT) were identified. The three key parameters will be estimated when sensitivity is modeled as a function of the sojourn time and time spent in the preclinical state using our new likelihood method. This lays a foundation for predictions and estimations in Aim 2, since the future time interval is a function of the three key parameters; and we will plug in estimates of the three key parameters in Aim 2 to obtain the optimal screening time. 2. To schedule the next screening exam dynamically for an asymptomatic individual with any screening history. A new method using conditional probability of incidence before the next exam is proposed. The next screening time is found by limiting this probability to a small value, to guarantee early detection and control the risk of over-diagnosis. The lead-time distribution and the probability of over-diagnosis are derived, if one would be diagnosed with cancer at the next proposed screening time, so that predictive information can be provided to individuals on how early his/her disease could be detected, and the risk of over-diagnosis if one undergoes screening exams as suggested. 3. To develop a user-friendly software for Aims 1 and 2, and made available to the public. In summary policy makers can use information from this research to recommend future screening frequencies for different risk groups (e.g., age, gender, smoking status) under different screening techniques (X-ray or CT). Physicians may use results from Aim 3 (the developed software) to schedule the next exam for individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Statistical Inference for Lead Time in Cancer Screening
  • 批准号:
    6938206
  • 项目类别:
  • 资助金额:
    $6.77万
  • 财政年份:
    2005
  • 负责人:
    Dongfeng Wu
  • 依托单位:
Statistical Inference for Lead Time in Cancer Screening
  • 批准号:
    7047845
  • 项目类别:
  • 资助金额:
    $6.82万
  • 财政年份:
    2005
  • 负责人:
    Dongfeng Wu
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: